Contact details

Type of addressPostal address
Postal codeYO10 5DD
CountryUnited Kingdom
Address lines
  • Centre for Health Economics
    University of York
    Heslington
    York
    YO10 5DD

Phone: (01904) 321434

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations

Prof. Stephen John Palmer

Professor

  1. 2019
  2. 2018
  3. 2017
  4. Population-adjusted treatment comparisons: estimates based on Matching-Adjusted Indirect Comparison and Simulated Treatment Comparison

    Phillippo, D., Ades, T., Dias, S., Palmer, S., Abrams, K. & Welton, N. J., 1 Jul 2017.

    Research output: Contribution to conferencePaper

  5. NICE DSU technical support document 19: partitioned survival analysis for decision modelling in health care: a critical review

    Woods, B. S., Sideris, E., Palmer, S. J., Latimer, N. & Soares, M. F. O., 2 Jun 2017, NICE Decision Support Unit. 72 p. (Technical Support Document)

    Research output: Book/ReportCommissioned report

  6. Population-adjusted treatment comparisons: estimates based on MAIC (Matching-Adjusted Indirect Comparisons) and STC (Simulated Treatment Comparisons)

    Phillippo, D., Ades, T., Dias, S., Palmer, S., Abrams, K. & Welton, N. J., 1 May 2017.

    Research output: Contribution to conferencePaper

  7. 2016
  8. NICE DSU Technical Support Document 18: Methods for population-adjusted indirect comparisons in submissions to NICE

    Phillippo, D., Ades, T., Dias, S., Palmer, S., Abrams, K. R. & Welton, N. J., 1 Dec 2016, NICE Decision Support Unit. (Technical Support Documents)

    Research output: Book/ReportBook

  9. Using electronic health records to predict costs and outcomes in stable coronary artery disease

    Asaria, M., Walker, S. M., Palmer, S. J., Gale, C., Shah, A. D., Abrams, K., Crowther, M., Manca, A., Timmis, A., Hemingway, H. & Sculpher, M., 10 Feb 2016

    Article in Heart

  10. 2015
  11. A randomised controlled trial of computerised cognitive behaviour therapy for the treatment of depression in primary care: the Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) trial

    Littlewood, E., Duarte, A., Hewitt, C., Knowles, S., Palmer, S., Walker, S., Andersen, P., Araya, R., Barkham, M., Bower, P., Brabyn, S., Brierley, G., Cooper, C., Gask, L., Kessler, D., Lester, H., Lovell, K., Usman, M., Parry, G., Richards, D. A. & 5 othersRichardson, R., Tallon, D., Tharmanathan, P., White, D. & Gilbody, S. M., 19 Dec 2015

    Article in Health Technol Assess

  12. Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme.

    Ara, R., Duarte, A. I., Harnan, S., Leaviss, J., Palmer, S. J., Sculpher, M. & Brazier, J., 2015, Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU). 82 p.

    Research output: Book/ReportCommissioned report

  13. 2014
  14. Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost effectiveness and value of a further randomised controlled trial

    Soares, M. O., Welton, N. J., Harrison, D. A., Peura, P., Shankar-Hari, M., Harvey, S. E., Madan, J., Ades, A. E., Rowan, K. M. & Palmer, S. J., 1 Dec 2014

    Article in Critical Care

  15. Getting cost-effective technologies into practice: the value of implementation.

    Walker, S. M., Faria, R., Palmer, S. J. & Sculpher, M., 2014, Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU).

    Research output: Book/ReportCommissioned report

  16. Getting cost-effective technologies into practice: the value of implementation: Initial scoping review for phase 1

    Essat, M., Faria, R., Gomersall, T., Grimm, S., Keetharuth, A., Walker, S. M., Dixon, S., Palmer, S. J. & Sculpher, M., 2014, Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU). 172 p.

    Research output: Book/ReportCommissioned report

  17. 2013
  18. 2012
  19. Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions

    Walker, S. M., Sculpher, M., Claxton, K. P. & Palmer, S. J., Apr 2012, York UK: Centre for Health Economics, University of York. 40 p. (CHE Research Paper; no. 77)

    Research output: Book/ReportOther report

  20. Appropriate perspectives for health care decisions

    Walker, S. M., Griffin, S., Claxton, K. P., Palmer, S. J. & Sculpher, M., 2012, Unit costs of health and social care 2012. Canterbury: PSSRU University of Kent

    Research output: Chapter in Book/Report/Conference proceedingChapter

  21. 2011
  22. Uncertainty, evidence and irrecoverable costs: informing approval, pricing and research decisions for health technologies

    Claxton, K. P., Palmer, S. J., Longworth, L., Bojke, L., Griffin, S., McKenna, C., Soares, M. O., Spackman, E. & Youn, J., Oct 2011, York, UK: Centre for Health Economics, University of York, 81 p. (CHE Research Paper; no. 69).

    Research output: Working paper

  23. Fingolimod for the treatment of relapsing remitting multiple sclerosis

    CRD and CHE Technology Assessment Group, Asaria, M., Norman, G., Hinde, S., O'Connor, J., Palmer, S. J., Light, K., O Soares, M. & Eastwood, A. J., Jun 2011, Centre for Reviews and Dissemination/ Centre for Health Economics.

    Research output: Book/ReportCommissioned report

  24. 2010
  25. Evaluating the Quality of Research into a Single Prognostic Biomarker: A Systematic Review and Meta-analysis of 83 Studies of C-Reactive Protein in Stable Coronary Artery Disease

    Hemingway, H., Philipson, P., Chen, R., Fitzpatrick, N. K., Damant, J., Shipley, M., Abrams, K. R., Moreno, S., McAllister, K. S. L., Palmer, S., Kaski, J. C., Timmis, A. D. & Hingorani, A. D., Jun 2010

    Literature review in Plos medicine

  26. Primary angioplasty versus thrombolysis for acute ST-elevation myocardial infarction: an economic analysis of the National Infarct Angioplasty project

    Wailoo, A., Goodacre, S., Sampson, F., Alava, M. H., Asseburg, C., Palmer, S., Sculpher, M., Abrams, K., de Belder, M. & Gray, H., May 2010

    Article in Heart

  27. Trastuzumab for the treatment of HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction

    CRD and CHE Technology Assessment Group, Norman, G., Rice, S. J., Spackman, E., Stirk, L., Danso-Appiah, T., Suh, D., Palmer, S. J. & Eastwood, A. J., May 2010, Centre for Reviews and Dissemination/ Centre for Health Economics.

    Research output: Book/ReportCommissioned report

  28. The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model

    Hemingway, H., Henriksson, M., Chen, R., Damant, J., Fitzpatrick, N., Abrams, K., Hingorani, A., Janzon, M., Shipley, M., Feder, G., Keogh, B., Stenestrand, U., McAllister, K., Kaski, J-C., Timmis, A., Palmer, S. & Sculpher, M., Feb 2010

    Article in Health technology assessment

  29. Assessing the cost effectiveness of using prognostic biomarkers with decision models: case study in prioritising patients waiting for coronary artery surgery

    Henriksson, M., Palmer, S., Chen, R., Damant, J., Fitzpatrick, N. K., Abrams, K., Hingorani, A. D., Stenestrand, U., Janzon, M., Feder, G., Keogh, B., Shipley, M. J., Kaski, J-C., Timmis, A., Sculpher, M. & Hemingway, H., 19 Jan 2010

    Article in British medical journal

  30. Appropriate perspectives for health care decisions.

    Claxton, K., Palmer, S., Sculpher, M. & Walker, S., 2010, York, UK: Centre for Health Economics, University of York, 86 p. (CHE Research Paper; no. 54).

    Research output: Working paperDiscussion paper

  31. 2009
  32. Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation.

    Burch, J., Paulden, M., Conti, S., Stock, C., Corbett, M., Welton, N. J., Ades, A. E., Sutton, A., Cooper, N., Elliot, A. J., Nicholson, K., Duffy, S., McKenna, C., Stewart, L., Westwood, M. & Palmer, S., Nov 2009

    Article in Health technology assessment

  33. Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia

    Walker, S., Palmer, S., Erhorn, S., Brent, S., Dyker, A., Ferrie, L., Horsley, W., Macfarlane, S., White, S. & Thomas, S., Jun 2009

    Article in Health technology assessment

  34. Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix

    CRD and CHE Technology Assessment Group, Paton, F. C. W., Paulden, M., Saramago, P., Manca, A., Misso, K., Palmer, S. J. & Eastwood, A. J., Apr 2009, Centre for Reviews and Dissemination/ Centre for Health Economics.

    Research output: Book/ReportCommissioned report

  35. The use of paclitaxel in the management of early stage breast cancer.

    Griffin, S., Dunn, G., Palmer, S., Macfarlane, S., Brent, S., Dyker, A., Erhorn, A., Humphries, C., White, S., Horsley, W., Ferrie, L. & Thomas, S., 2009.

    Research output: Working paper

  36. 2008
  37. The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial

    Henriksson, M., Epstein, D. M., Palmer, S. J., Sculpher, M. J., Clayton, T. C., Pocock, S. J., Henderson, R. A., Buxton, M. J. & Fox, K. A. A., Jun 2008

    Article in Heart

  38. Modelling strategies to address childhood overweight and obesity in the UK: An exploratory cost-utility analysis

    Nixon, J., Fayter, D., Hartley, S., Rithalia, A., Stirk, L., Westwood, M., Palmer, S., Rudolf, M., Glasziou, P., Bland, M. & Butler, G., 2008

    Article in Hormone research

  39. 2007
Previous 1 2 Next